Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

PRP therapy helps skin heal and improve by promoting cell growth and repair.

Using electronic health records can help identify drug side effects but has some limitations.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

PRP's benefits for treating scarring hair loss are still uncertain.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Two genes, ERBB4 and ROR1, may cause the unique pigmentation in Lanping black-boned sheep.

MPA increases cancer spread by boosting Eph A2 activity.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

The 7.5% talok and 2% pare leaf extract hair tonic effectively promotes hair growth, similar to minoxidil.

Combining MSM with MAP significantly promotes hair growth.

Minoxidil, platelet-rich plasma, and microneedling all help with pattern hair loss, but their effectiveness varies.

miR-144 affects hair growth by interacting with Lhx2.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Standardizing the SMP procedure improves treatment results for hair loss.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Combining PRP with LLLT is most effective for hair growth in androgenetic alopecia.

HR protein causes abnormal hair cycles by increasing Tgf-β2 and reducing miR-31.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

PRP is not a stem cell treatment and should not be marketed as such.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.

SPARC likely aids in tissue remodeling during the hair cycle, not in starting new hair growth phases.